Upcoming Allied Market Research
Electronic Drug Delivery System Market

Electronic Drug Delivery System Market

Size, Share, Competitive Landscape and Trend Analysis Report by Type (Electronic Injection Pens, Electronic Wearable Infusion Pumps, Electronic Inhalers, Others) and by Indication (Diabetes, Cardiovascular Disease, Multiple Sclerosis, Asthma COPD, Other Indications): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A11257
Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.


Electronic Drug Delivery System Market Overview:

Electronic drug delivery systems (EDDS) represents a trend in the advancement and development of drug delivery systems, that are interactive, portable, wirelessly connected and allow patient-administered therapy dropping overall healthcare cost. Insulin pump is one of the most commonly used Electronic Drug Delivery System which can be utilized for management of diabetes. The upgrading of patient adherence when using prescribed medication is one of the driving forces in the development of EDDS. Additionally, EDDS have shown the potential to offer targeted drug delivery to particular sites in the body. The EDDS can be used nowadays for appropriate administration of drug to the targeted site.

COVID-19 scenario analysis:

The medical supplies important to help in the management of the infected population would boost in the current scenario. There is various respiratory support devices such as life-support machine, atomizer, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Furthermore, COVID-19 has led to a steep increase in the demand for medical supplies such as personal protective equipment including gloves, masks, and protective eyeglasses. With surge in number of COVID-19 cases globally, the need for medical supplies keeps on growing among, both from healthcare professionals and also among the civil population for precautionary measures. The manufacturers of these personal protective products have a chance to capitalize this augmented demand of medical supplies to ensure adequate and also continuous supply of personal protective equipment in the market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The key factors are anticipated to help the market grow in the near future that include growth in the prevalence of target and advancements in technologies and innovation in designs of electronic drug delivery system. Furthermore, favorable reimbursement scenario in majority of the markets would help the industry propel in the near future. However, disadvantages that are associated with the electronic device operation and the functionality would help the electronic drug delivery system market boost in the near future.

New product advancements to flourish the market

The increase in the development of the products according to the need of the industry would help the market grow in the near future. For instance, in March 2020, Diabeloop of Grenoble, had developed an external Type 1 diabetes management system, called as DBLG1, that connects three components, which are a patch-like insulin pump, continuous glucose monitor, and an artificial intelligence handset that contains Diabeloop’s self-learning algorithm and user interface

In May 2017, Aptar Pharma, which is among the leader in innovative drug delivery systems announced the approval by the European Medicines Agency (EMA) of its first integrated electronic nasal lockout device (e-Lockout) and also following a multi-year development with Takeda Pharmaceuticals International AG. Furthermore, Aptar Pharma agreed to supply Takeda with its e-Lockout device for a multidose nasal spray version of Instanyl. The EMA had granted marketing authorization for this multidose nasal spray treatment called Instanyl DoseGuardTM.

Surge in mergers and acquisitions to boost the market

The growth in the mergers and acquisition would help the key market players to show their presence in the market and hence gain maximum shares in the forecast period.  For instance, in July 2018, Swiss tech company Sensile Medical acquired by Gerresheimer, which is a glass and plastics manufacturer focusing in pharmaceutical packaging and drug delivery devices, with insulin pens and inhalers, in a deal worth up to €350 million with half upfront. The goal of merging the two companies includes developing new delivery systems with digital and electronic capabilities.

Key benefits of the report:

  • This study presents the analytical depiction of the global electronic drug delivery system market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Electronic Drug Delivery System market share.
  • The current market is quantitatively analyzed to highlight the global Electronic Drug Delivery System market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global Electronic Drug Delivery System market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Electronic Drug Delivery System Market research report:

  • What are the leading market players active in the Electronic Drug Delivery System market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in tasking further strategic steps?

Electronic Drug Delivery System Market Report Highlights

Aspects Details
By Type
  • Electronic Injection Pens
  • Electronic Wearable Infusion Pumps
  • Electronic Inhalers
  • Others
By Indication
  • Diabetes
  • Cardiovascular Disease
  • Multiple Sclerosis
  • Asthma & COPD
  • Other Indications
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Rest of LAMEA)
Key Market Players Insulet Corporation, Tandem Diabetes Care, Novo Nordisk, United Therapeutics Corporation, Merck Group Amgen, AstraZeneca, Medtronic plc., Companion Medical, Bayer AG, F. Hoffmann-La Roche

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Purchase Options

Call or Email Us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
Related Tags

Purchase Full Report of
Electronic Drug Delivery System Market

Start reading.
This Report and over 71,339+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Related Reports

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time for readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of the scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save the time of readers